NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.

Market Cap	$46.50M	P/E Ratio	N/A
52W High	$1.39	52W Low	$0.40
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	20.9%	52W Position	26.4%
Overall Score	48	Value Score	60
Quality Score	44	Technical Score	40

EPS Current Est	$-0.13	EPS Next Est	$-0.15
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NMTC	$0.66	+12.38%	403.20K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NMTC	$0.66	+12.4%	403.20K
3
4
5
6

NMTC

NMTC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get NeuroOne Medical Technologies Corporation Data in Excel

Get NeuroOne Medical Technologies Corporation Data in Excel